Macquarie Group’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$86.7K Hold
2,500
﹤0.01% 816
2026
Q1
$51.9K Buy
+2,500
New +$59.1K ﹤0.01% 790
2025
Q4
Sell
-419,932
Closed -$23.8M 1127
2025
Q3
$23.8M Buy
419,932
+281,808
+204% +$14.4M 0.03% 620
2025
Q2
$6.88M Sell
138,124
-4,483
-3% -$203K 0.01% 899
2025
Q1
$4.21M Sell
142,607
-121,996
-46% -$4.53M 0.01% 1021
2024
Q4
$6.4M Buy
+264,603
New +$6.56M 0.01% 894
2024
Q3
Sell
-82,054
Closed -$1.66M 1776
2024
Q2
$1.66M Buy
+82,054
New +$1.37M ﹤0.01% 1280
2021
Q2
Sell
-283,480
Closed -$3.75M 2561
2021
Q1
$3.75M Buy
+283,480
New +$4.75M 0.01% 994

Other funds holding HIMS

Macquarie Group's HIMS Position: Q2 2026 in Review

Macquarie Group held its Hims & Hers Health (HIMS) position steady in Q2 2026 at 2,500 shares worth $86.7K. The position accounts for ﹤0.01% of the portfolio, ranked #816.

Macquarie Group first reported a position in HIMS in Q1 2021 and has held it in 8 quarters since. The position peaked at $23.8M in Q3 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Macquarie Group held 2,500 shares of Hims & Hers Health worth $86.7K as of Q2 2026.
  • Macquarie Group left its Hims & Hers Health share count unchanged in Q2 2026.
  • Hims & Hers Health made up ﹤0.01% of Macquarie Group's portfolio in Q2 2026, its #816 holding.
  • Macquarie Group first reported a position in Hims & Hers Health in Q1 2021 and has held it in 8 quarters since.
  • Macquarie Group's Hims & Hers Health position peaked at $23.8M in Q3 2025.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Macquarie Group's 13F filing for Q2 2026, filed 14 Aug 2026.